Caulerpa racemosa harbors a rich reservoir of bioactive peptides derived from RuBisCO, a photosynthetic enzyme with promising therapeutic potential. This study aimed to systematically identify and characterize bioactive peptides from C. racemosa RuBisCO using a multi-step in silico pipeline. Simulated proteolysis using 33 enzymes predicted peptides with 35 different biological activities using BIOPEP-UWM. In addition to traditional database screening, further computational filtering was conducted using physicochemical profiling (ExPASy ProtParam), bioactivity prediction (PeptideRanker), toxicity and allergenicity evaluation (ToxinPred, AllergenFP), and structure-based molecular docking against relevant therapeutic targets—angiotensin-I converting enzyme (ACE, PDB: 1O8A) and xanthine oxidase (XO, PDB: 3NRZ). Four peptides with high predicted bioactivity scores (>0.75) showed strong binding affinity (−169.00 to −252.29 kcal/mol) and favorable confidence scores, suggesting their possible use as dual-action therapeutic agents—with both antihypertensive and antioxidant effects. This integrative in silico approach demonstrates the therapeutic relevance of C. racemosa peptides and provides a framework for peptide prioritization prior to experimental validation.
Primary Language | English |
---|---|
Subjects | Proteomics and Metabolomics, Bioinformatics and Computational Biology (Other) |
Journal Section | Research Articles |
Authors | |
Early Pub Date | August 2, 2025 |
Publication Date | October 9, 2025 |
Submission Date | August 5, 2024 |
Acceptance Date | July 9, 2025 |
Published in Issue | Year 2025 Volume: 34 Issue: 2 |
ULAKBIM TR Index, Scopus, Google Scholar, Crossref, Scientific Indexing Services